A systematic literature review on biological DMARDs for RA was previously undertaken to inform the 2010 EULAR RA management recommendations.
This review aims to provide an update on the efficacy of the currently available biological DMARDs from randomised controlled trials (RCTs) and to look at newer biological DMARDs in phase 3 RCTs.
Disclosure of Interest None Declared
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.